SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments.With over $2 billion in capital under management in seven private healthcare funds, a 20-year track record in the US and Europe and offices in Boston, San Francisco and London, SV Health Investors drives game-changing innovation.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
Apr 15, 2021
Alchemab Therapeutics
|
Series A | £60M | Biotechnology | — |
Apr 26, 2017
Arsanis
|
Series D | $45.50M | Biotechnology | — |
Dec 30, 2016
Good Start Genetics
|
Debt Financing | — | Biotechnology | — |
Jul 29, 2016
Good Start Genetics
|
Debt Financing | — | Biotechnology | — |